Last reviewed · How we verify
NCT03860363
Experiences With Automated Surgical Drainage in Cardiac Surgery
trial testing Blood drainage post cardiac surgery in Hemorrhage in 28 participants. Completed in 30 May 2020.
30 March 2020
Quick facts
| Lead sponsor | Centese, Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 28 |
| Start date | 22 February 2019 |
| Primary completion | 30 March 2020 |
| Estimated completion | 30 May 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Blood drainage post cardiac surgery
Conditions studied
- Hemorrhage — all drugs for Hemorrhage →
Sponsor
Centese, Inc.
Who can join
18 and older, any sex, with Hemorrhage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the Thoraguard Surgical Drainage System in a real-world clinical environment. It is believed that this system will offer functional and clinical benefits over the current standard of care system for the removal of surgical fluids following cardiac surgery. Observations, experiences, and outcomes in a single hospital setting will be collected for the Thoraguard Surgical Drainage System.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
An automated line-clearing chest tube system after cardiac surgery.
Obafemi OO, Wang H, Bajaj SS, O'Donnell CT, et al · · 2022 · cited 4× · PMID 36004272 · DOI 10.1016/j.xjon.2022.02.020
Verify or expand the search:
- PubMed search for NCT03860363
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hemorrhage
Currently open trials in the same condition.
- NCT07311343 — Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia · Phase 4 · recruiting
- NCT07105904 — Biological and Clinical Relevance of Quantra Viscoelastic Hemostatic Assay in Hemorrhagic Cardiac Surgery · active not recruiting
- NCT06979466 — Q Therapeutic System for Chronic Stroke Recovery · NA · recruiting
- NCT06664775 — A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate S · Phase 3 · recruiting
- NCT06304714 — Effects of Bothrops Spp. Snake Envenomation on Willebrand Factor Activity in Martinique and French Guiana · recruiting
Other Centese, Inc. trials
Trials by the same sponsor.
- NCT04068545 — Experiences With New Digital Surgical Drainage System in Thoracic Surgery · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03860363 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centese, Inc.
- Last refreshed: 17 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03860363.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing